Evercore ISI Group Maintains Outperform on Repligen, Lowers Price Target to $140

Benzinga Newsdesk www.benzinga.com Negative 95.3%

Neg 95.3% Neu 0% Pos 0%

Evercore ISI Group analyst Daniel Markowitz maintains Repligen (NASDAQ:RGEN) with a Outperform and lowers the price target from $170 to $140.